Navigation Links
Isis Announces Appointment of B. Lynne Parshall as Chief Operating Officer
Date:12/14/2007

nts. Although Isis' forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by Isis. As a result, you are cautioned not to rely on these forward-looking statements. These and other risks concerning Isis' programs are described in additional detail in Isis' annual report on Form 10-K for the year ended December 31, 2006, and its quarterly report on Form 10-Q for the quarter ended September 30, 2007, which are on file with the SEC. Copies of these and other documents are available from the Company.

In this press release, unless the context requires otherwise, "Isis," "Company," "we," "our," and "us" refers to Isis Pharmaceuticals and its subsidiaries.

Isis Pharmaceuticals is a registered trademark of Isis Pharmaceuticals, Inc. Ibis Biosciences and Ibis T5000 are trademarks of Ibis Biosciences, Inc. Regulus Therapeutics is a trademark of Regulus Therapeutics LLC.


'/>"/>
SOURCE Isis Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... -- Reportlinker.com announces that a new market r..., Drug Discovery Technologies - A Global Update o.../www.reportlinker.com/p0164246/Drug-Discovery-Tech...tunities.html ,, Drug discovery has become an ...al company,s business strategy. There are a number...
(Date:12/2/2009)...FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics"...ced today that in connection with its previously a...cised in full their over-allotment option and purc...mprised of one common share and 0.4 of a common sh...S$3.00 per unit. Each whole common share purchase ...
(Date:12/2/2009)...ber 2 Gamida Cell announced today,...imal study) safety and,efficacy of a gene therapy ...ll Medical College and Gamida Cell. The product ma...s Cooley,s Anemia. , Gamida Cell is devel...,populations of stem/progenitor cells. The company...
(Date:12/2/2009)...stCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ; T...al company focused on endocrine therapy and oncolo...ministration (FDA) has granted Fast Track designat...ompound, perifosine (KRX-0401), for the treatment ...pharmaceuticals, Inc. ("Keryx") ( KERX), is AEtern...
Breaking Biology Technology:Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3
...eb. 11 Caliper Life,Sciences, Inc. (Nasdaq: CALP...utsche Bank 2008 Small and Mid Cap Growth Conferen..., February 13 at 4:40 p.m. EST. Kevin,Hrusovsky, P...update on the,company,s business. The live webcast...reye/confLobby.zhtml?ticker=CALP&item_id=17485 ,73...
...s Potential New Short-Course Treatment Option for ...luding MRSA, CAMBRIDGE, Mass., Feb. 11 Targanta,...d today that it has,submitted a New Drug Applicati...(FDA) for its lead antibiotic candidate, oritavanc...otic candidate with potent,bactericidal (killing) ...
...e real-world clinical data on the PROMUS(TM) Stent...ration (NYSE: BSX ) today announced that the firs...(TM), ENdeavor(R) and CYpher(R)) European,registry...Olimus,-eluting,coronary stents. It will collect r...ic,s PROMUS(TM) Everolimus-Eluting Coronary Stent ...
Other Biology Technology:Targanta Submits Oritavancin New Drug Application 2Targanta Submits Oritavancin New Drug Application 3Targanta Submits Oritavancin New Drug Application 4Boston Scientific Announces Start of Major European Registry Assessing Different Olimus-Eluting Stents 2Boston Scientific Announces Start of Major European Registry Assessing Different Olimus-Eluting Stents 3Boston Scientific Announces Start of Major European Registry Assessing Different Olimus-Eluting Stents 4
(Date:12/3/2009)... snubbing? Your genetics, not your friends, may be...um-like painkillers, called opioids, relieve not o...l stress. Now, a new study reviewed by Faculty of ... genetic differences in the gene for the opioid re...ponses to social rejection. , In the study publ...
(Date:12/3/2009)...estment in energy efficient technologies research,...uncil (EPSRC) Chief Executive Dave Delpy believes ...esearch has already brought us fuel cells, marine,...nt is needed to develop the capabilities of differ...n targets by 2020 and limit the impact of climate ...
(Date:12/2/2009)...and cigarette smoke have an increased risk of deve...r smoked. , Results of this study are published..., a journal of the American Association for Cancer...he December issue. , This year alone, more than...cer; more than 159,000 will die from it and some o...
Breaking Biology News(10 mins):Research is vital to a cleaner, greener, low carbon future 2Secondhand smoke exposure in childhood increases lung cancer risk later in life 2Sugarcane as a Key Element Against Global Warming to be Highlighted at Green Week in Brussels 12749 1Sugarcane as a Key Element Against Global Warming to be Highlighted at Green Week in Brussels 12749 2Sugarcane as a Key Element Against Global Warming to be Highlighted at Green Week in Brussels 12749 3Sugarcane as a Key Element Against Global Warming to be Highlighted at Green Week in Brussels 12749 4Need something 3F Talk to my right ear 21 49772 1Need something 3F Talk to my right ear 21 49772 2Lack of happiness hormone serotonin in the brain causes impaired maternal behavior in mice 8972 1
...ockfish (Sebastes sp.) took place in the Central G...corporated fishery cooperatives instead of the usu...dicate increased retention rates, reduced bycatch ...ther benefits to the Kodiak Island community. , I... in slowing the pace of the fishery, improving pro...
... with blue eyes have a single, common ancestor. A ...down a genetic mutation which took place 6-10,000 ...l blue-eyed humans alive on the planet today. , ...l had brown eyes, said Professor Eiberg from the D... genetic mutation affecting the OCA2 gene in our c...
...ted to the framed journal covers decorating his of...ting, complicated structure of an enzyme. Those br...s lab. And theyre part of Reillys work to understa...echanism and its activity. , In other words, hes...work, said Reilly, a professor of chemical and bio...
Other Biology News:A pilot program for harvesting Kodiak rockfish 2A pilot program for harvesting Kodiak rockfish 3Blue-eyed humans have a single, common ancestor 2Iowa State researcher studies how enzymes break down cellulose 2
PCNA Immunohistochemistry Assay Kit from Invitrogen
Varian Cary 6000i Spectrophotometer from Varian, Inc.
Gln(Trt) Peptide Synthesis Column from Applied Biosystems
E. coli Expression System with Gateway Technology from Invitrogen
Biology Products: